Titan Pharmaceuticals Faces Nasdaq Compliance Challenges Amid Strategic Merger
In a significant development for investors and stakeholders, Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is navigating turbulent waters with the recent announcement of its non-compliance with Nasdaq’s continued listing r...
Nov 27, 2024
• Biotechnology & Pharmaceuticals Industry
Stock Market Announcement